Patents
Literature
Eureka-AI is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Eureka AI

4563results about How to "Reduce incidence" patented technology

Selective androgen receptor modulators and methods of use thereof

InactiveUS6998500B2Reduce incidenceDecreasing regressionBiocideTin organic compoundsDiseaseAging male
This invention provides a class of androgen receptor targeting agents (ARTA). The agents define a new subclass of compounds, which are selective androgen receptor modulators (SARM). Several of the SARM compounds have been found to have an unexpected androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. Other SARM compounds have been found to have an unexpected antiandrogenic activity of a nonsteroidal ligand for the androgen receptor. The SARM compounds, either alone or as a composition, are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and / or prevention of acute and / or chronic muscular wasting conditions; e) preventing and / or treating dry eye conditions; f) oral androgen replacement therapy; and / or g) decreasing the incidence of, halting or causing a regression of prostate cancer.
Owner:UNIV OF TENNESSEE RES FOUND

N-bridged selective androgen receptor modulators and methods of use thereof

ActiveUS7022870B2Unexpected antiandrogenic activityDecrease libidoBiocideSenses disorderErectile dysfunctionAging male
This invention provides a class of androgen receptor targeting agents (ARTA). The agents define a new subclass of compounds, which are selective androgen receptor modulators (SARM). Several of the SARM compounds have been found to have an unexpected androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. Other SARM compounds have been found to have an unexpected antiandrogenic activity of a nonsteroidal ligand for the androgen receptor. The SARM compounds, either alone or as a composition, are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and/or prevention of acute and/or chronic muscular wasting conditions; e) preventing and/or treating dry eye conditions; f) oral androgen replacement therapy; and/or g) decreasing the incidence of, halting or causing a regression of prostate cancer.
Owner:UNIV OF TENNESSEE RES FOUND

System for achieving fatigue driving judgment on basis of image processing and fusion between heart rate characteristic and expression characteristic

The invention discloses a system for achieving fatigue driving judgment on the basis of image processing and fusion between the heart rate characteristic and the expression characteristic. The system comprises an information collection device, an information processing device and an early warning device. The system is characterized in that the information collection device is used for collecting a driver face image sequence, and providing the driver face image sequence for the information processing device; the information processing device is used for carrying out processing and analysis on the collected driver face image sequence to obtain expression characteristic information and heart rate characteristic information of a driver, and carrying out information fusion on the expression characteristic and the heart rate characteristic so that whether the driver is in the fatigue state or not can be judged; the early warning device is used for sending an instruction to an early warning prompting device according to the early warning strategy and the fatigue level when the driver is in fatigue driving, and carrying out prompting and early warning on the driver. According to the system for achieving fatigue driving judgment on the basis of image processing and fusion between the heart rate characteristic and the expression characteristic, the heart rate characteristic and the expression characteristic are combined through an image processing method, a fatigue driving judgment algorithm is achieved, a vehicle-mounted fatigue driving judgment device is obtained, and accuracy, robustness and reliability of the system for achieving fatigue driving judgment are improved.
Owner:SUZHOU TSINGTECH MICROVISION ELECTRONICS TECH +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products